Literature DB >> 30315306

Grading of Atrophic Gastritis is Useful for Risk Stratification in Endoscopic Screening for Gastric Cancer.

Kyosuke Kaji1, Atsushi Hashiba, Chika Uotani, Yasushi Yamaguchi, Toshio Ueno, Kenji Ohno, Ichiro Takabatake, Tokio Wakabayashi, Hisashi Doyama, Itasu Ninomiya, Masato Kiriyama, Shigekazu Ohyama, Manabu Yoneshima, Nobu Koyama, Yasuo Takeda, Kenji Yasuda.   

Abstract

OBJECTIVES: In order to screen for gastric cancer effectively, its interval should be set according to the risk. This study aimed to determine whether risk stratification is possible using the data obtained from medical examination or endoscopic findings.
METHODS: First, subjects who underwent both cancer screening and medical examination from 2009 to 2015 and underwent cancer screening once more by 2016 were studied. Data such as the lipid profile and history of smoking obtained during the medical examination, and the grade of atrophy and presence of peptic ulcers were studied using multivariate analysis. Next, subjects who underwent cancer screening twice or more between 2009 and 2015 with or without medical examinations were studied to analyze any correlation between the grade of atrophy and cancer occurrence using univariate analysis. In both studies, the status of Helicobacter pylori (HP) infection was determined.
RESULTS: In the multivariate analysis, 9378 subjects were included. Aging, advanced atrophy, presence of ulcers, and uric acid levels were identified as risk factors. Among subjects who underwent successful HP eradication therapy, advanced atrophy and aging were observed to be crucial risk factors. In the univariate analysis, there were 12,941 subjects. Gastric cancer occurred more frequently in the more severe atrophy group (P < 0.001). The annual rate of cancer occurrence in the most severe atrophy group was 0.31%, which was approximately thrice as that in the less atrophy group.
CONCLUSIONS: Risk stratification was possible based on endoscopic examination alone. The interval should be set depending on each case.

Entities:  

Mesh:

Year:  2019        PMID: 30315306     DOI: 10.1038/s41395-018-0259-5

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  16 in total

1.  Time trends in the incidence of esophageal adenocarcinoma, gastric adenocarcinoma, and superficial esophagogastric junction adenocarcinoma.

Authors:  Kenshi Matsuno; Ryu Ishihara; Masayasu Ohmori; Hiroyoshi Iwagami; Satoki Shichijyo; Akira Maekawa; Takashi Kanesaka; Sachiko Yamamoto; Yoji Takeuchi; Koji Higashino; Noriya Uedo; Takashi Matsunaga; Toshitaka Morishima; Isao Miyashiro
Journal:  J Gastroenterol       Date:  2019-03-29       Impact factor: 7.527

2.  Gastric cancer risk stratification and surveillance after Helicobacter pylori eradication: 2020.

Authors:  Mimi C Tan; David Y Graham
Journal:  Gastrointest Endosc       Date:  2019-09       Impact factor: 9.427

Review 3.  Chronic inflammation and long-lasting changes in the gastric mucosa after Helicobacter pylori infection involved in gastric cancer.

Authors:  Hang Yang; Bin Wei; Bing Hu
Journal:  Inflamm Res       Date:  2021-09-21       Impact factor: 4.575

4.  Helicobacter pylori eradication improved the Kyoto classification score on endoscopy.

Authors:  Osamu Toyoshima; Toshihiro Nishizawa; Kosuke Sakitani; Tadahiro Yamakawa; Yoshiyuki Takahashi; Kazunori Kinoshita; Akira Torii; Atsuo Yamada; Hidekazu Suzuki; Kazuhiko Koike
Journal:  JGH Open       Date:  2020-05-29

Review 5.  Endoscopic Kyoto classification of Helicobacter pylori infection and gastric cancer risk diagnosis.

Authors:  Osamu Toyoshima; Toshihiro Nishizawa; Kazuhiko Koike
Journal:  World J Gastroenterol       Date:  2020-02-07       Impact factor: 5.742

Review 6.  Previous Helicobacter pylori infection-induced atrophic gastritis: A distinct disease entity in an understudied population without a history of eradication.

Authors:  Hiroshi Kishikawa; Keisuke Ojiro; Kenji Nakamura; Tadashi Katayama; Kyoko Arahata; Sakiko Takarabe; Soichiro Miura; Takanori Kanai; Jiro Nishida
Journal:  Helicobacter       Date:  2019-11-03       Impact factor: 5.753

7.  Endoscopic severe mucosal atrophy indicates the presence of gastric cancer after Helicobacter pylori eradication -analysis based on the Kyoto classification.

Authors:  Akiko Ohno; Jun Miyoshi; Atsushi Kato; Naohiko Miyamoto; Takahito Yatagai; Yu Hada; Mitsunori Kusuhara; Yoko Jimbo; Yosuke Ida; Kengo Tokunaga; Susumu Okamoto; Tadakazu Hisamatsu
Journal:  BMC Gastroenterol       Date:  2020-07-20       Impact factor: 3.067

8.  A study protocol for expanding the screening interval of endoscopic screening for gastric cancer based on individual risks: prospective cohort study of gastric cancer screening.

Authors:  Chisato Hamashima; Kenichi Yoshimura; Akira Fukao
Journal:  Ann Transl Med       Date:  2020-12

Review 9.  Artificial Intelligence in Endoscopy.

Authors:  Yutaka Okagawa; Seiichiro Abe; Masayoshi Yamada; Ichiro Oda; Yutaka Saito
Journal:  Dig Dis Sci       Date:  2021-06-21       Impact factor: 3.199

10.  Different Metabolites of the Gastric Mucosa between Patients with Current Helicobacter pylori Infection, Past Infection, and No Infection History.

Authors:  Su-Young Son; Choong-Hwan Lee; Sun-Young Lee
Journal:  Biomedicines       Date:  2022-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.